SEC Form 4 · accession 0001209191-16-096145
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey R Luber
Director
Period of report
Feb 4, 2016
Accepted (ET)
Feb 5, 2016 · 7:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $0.29 | Feb 4, 2016 | A | 10,000 | A | — | Feb 4, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy for joining the board of directors. The option vests as to one hundred percent of the shares on February 4, 2017.